Skip to content

Author

Shi-Peng Ning

We have 3 of 44 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Electrochemical Valence‐Regulated Biomimetic Nanozymes for Breast Cancer Metabolism Inhibition and Potentiated Catalytic Immunotherapy

MnOx nanozymes with precisely controllable valence states via electrochemical valence regulation to modulate their oxidase‐like activity are fabricated to form biomimetic nanozymes (TMO), which efficiently targets tumors and induces immunogenic cell death via oxidase catalytic therapy.

You Pan, Wei Cai, Meng Suo et al. · 0 citations
Open access Sep 2026

Organic Nanozyme‐Embedded Biotherapeutic Thermosensitive Hydrogel for Extracellular GSH Depletion and Postoperative Tumor Suppression

A multifunctional hydrogel loaded with a novel cyanine nanozyme and Escherichia coli combines efficient photothermal therapy, photodynamic therapy, and peroxidase‐like enzyme activity to provide a novel and effective strategy for postoperative tumor therapy and recurrence inhibition.

Cong Jiang, Zi-Fan Yang, Rong Guo et al. · 0 citations
Review Open access Jul 2026

Personalized cancer vaccines: bridging immune-oncology and precision medicine for advanced therapeutics

Next-generation personalized cancer vaccines are advancing the transition from reactive treatment to proactive, precision-controlled cancer immunotherapy, and when integrated with artificial intelligence for antigen selection and multiomics for patient stratification, these platforms accelerate vaccine design and impro...

L. Ye, GuoWei Zhao, Jiaxiu Ma et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.